These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10230610)

  • 1. Synthesis and structure-activity relationship of potent bicyclic lactam thrombin inhibitors.
    Bachand B; DiMaio J; Siddiqui MA
    Bioorg Med Chem Lett; 1999 Apr; 9(7):913-8. PubMed ID: 10230610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel bicyclic lactam inhibitors of thrombin: potency and selectivity optimization through P1 residues.
    Lévesque S; St-Denis Y; Bachand B; Préville P; Leblond L; Winocour PD; Edmunds JJ; Rubin JR; Siddiqui MA
    Bioorg Med Chem Lett; 2001 Dec; 11(24):3161-4. PubMed ID: 11720865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and SAR of centrally active mGlu5 positive allosteric modulators based on an aryl acetylenic bicyclic lactam scaffold.
    Williams R; Manka JT; Rodriguez AL; Vinson PN; Niswender CM; Weaver CD; Jones CK; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1350-3. PubMed ID: 21315585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel, potent non-covalent thrombin inhibitors incorporating p(3)-lactam scaffolds.
    Ho JZ; Gibson TS; Semple JE
    Bioorg Med Chem Lett; 2002 Mar; 12(5):743-8. PubMed ID: 11858993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel bicyclic lactam inhibitors of thrombin: highly potent and selective inhibitors.
    St-Denis Y; Lévesque S; Bachand B; Edmunds JJ; Leblond L; Préville P; Tarazi M; Winocour PD; Siddiqui MA
    Bioorg Med Chem Lett; 2002 Apr; 12(8):1181-4. PubMed ID: 11934583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent and selective bicyclic lactam inhibitors of thrombin. Part 4: transition state inhibitors.
    Bachand B; Tarazi M; St-Denis Y; Edmunds JJ; Winocour PD; Leblond L; Siddiqui MA
    Bioorg Med Chem Lett; 2001 Feb; 11(3):287-90. PubMed ID: 11212093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and cognition activating properties of some mono- and bicyclic lactam derivatives.
    Altomare C; Carotti A; Casini G; Cellamare S; Ferappi M; Gavuzzo E; Mazza F; Pantaleoni G; Giorgi R
    J Med Chem; 1988 Nov; 31(11):2153-8. PubMed ID: 3184123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and evolution of a novel, selective, and orally bioavailable class of thrombin inhibitors: P1-argininal derivatives incorporating P3-P4 lactam sulfonamide moieties.
    Semple JE; Rowley DC; Brunck TK; Ha-Uong T; Minami NK; Owens TD; Tamura SY; Goldman EA; Siev DV; Ardecky RJ; Carpenter SH; Ge Y; Richard BM; Nolan TG; Håkanson K; Tulinsky A; Nutt RF; Ripka WC
    J Med Chem; 1996 Nov; 39(23):4531-6. PubMed ID: 8917639
    [No Abstract]   [Full Text] [Related]  

  • 9. Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modifications.
    St-Denis Y; Augelli-Szafran CE; Bachand B; Berryman KA; DiMaio J; Doherty AM; Edmunds JJ; Leblond L; Lévesque S; Narasimhan LS; Penvose-Yi JR; Rubin JR; Tarazi M; Winocour PD; Siddiqui MA
    Bioorg Med Chem Lett; 1998 Nov; 8(22):3193-8. PubMed ID: 9873701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent integrin antagonists from a small library of RGD-including cyclic pseudopeptides.
    Belvisi L; Bernardi A; Checchia A; Manzoni L; Potenza D; Scolastico C; Castorina M; Cupelli A; Giannini G; Carminati P; Pisano C
    Org Lett; 2001 Apr; 3(7):1001-4. PubMed ID: 11277780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modifications.
    Plummer JS; Berryman KA; Cai C; Cody WL; DiMaio J; Doherty AM; Edmunds JJ; He JX; Holland DR; Levesque S; Kent DR; Narasimhan LS; Rubin JR; Rapundalo ST; Siddiqui MA; Susser AJ; St-Denis Y; Winocour PD
    Bioorg Med Chem Lett; 1998 Dec; 8(23):3409-14. PubMed ID: 9873743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of pipecolic acid-based spiro bicyclic lactam scaffolds as beta-turn mimics.
    Somu RV; Johnson RL
    J Org Chem; 2005 Jul; 70(15):5954-63. PubMed ID: 16018691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo properties of bicyclic lactam inhibitors: a novel class of low molecular weight peptidomimetic thrombin inhibitors.
    Leblond L; Grouix B; Boudreau C; Yang Q; Siddiqui MA; Winocour PD
    Thromb Res; 2000 Nov; 100(3):195-209. PubMed ID: 11108907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonpeptide RGD antagonists: a novel class of mimetics, the 5,8-disubstituted 1-azabicyclo[5.2.0]nonan-2-one lactam.
    Bourguet E; Banères JL; Parello J; Lusinchi X; Girard JP; Vidal JP
    Bioorg Med Chem Lett; 2003 May; 13(9):1561-4. PubMed ID: 12699755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activity of some monocyclic- and bicyclic beta-lactams with specified functional groups.
    Hwu JR; Ethiraj KS; Hakimelahi GH
    Mini Rev Med Chem; 2003 Jun; 3(4):305-13. PubMed ID: 12678824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo characterization of a neutral boron-containing thrombin inhibitor.
    Tapparelli C; Metternich R; Ehrhardt C; Zurini M; Claeson G; Scully MF; Stone SR
    J Biol Chem; 1993 Mar; 268(7):4734-41. PubMed ID: 8444849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and dopamine receptor modulating activity of substituted bicyclic thiazolidine lactam peptidomimetics of L-prolyl-L-leucyl-glycinamide.
    Khalil EM; Pradhan A; Ojala WH; Gleason WB; Mishra RK; Johnson RL
    J Med Chem; 1999 Jul; 42(15):2977-87. PubMed ID: 10425107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amide and alpha-keto carbonyl inhibitors of thrombin based on arginine and lysine: synthesis, stability and biological characterization.
    Brady SF; Sisko JT; Stauffer KJ; Colton CD; Qiu H; Lewis SD; Ng AS; Shafer JA; Bogusky MJ; Veber DF
    Bioorg Med Chem; 1995 Aug; 3(8):1063-78. PubMed ID: 7582980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-Component 1,2-Carboamidation of Bridged Bicyclic Alkenes via Rh
    Brandes DS; Sirvent A; Mercado BQ; Ellman JA
    Org Lett; 2021 Apr; 23(7):2836-2840. PubMed ID: 33739839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric synthesis and antimicrobial activity of some new mono and bicyclic beta-lactams.
    Jarrahpour AA; Shekarriz M; Taslimi A
    Molecules; 2004 Nov; 9(11):939-48. PubMed ID: 18007494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.